Gardasil
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
219 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Papillomavirus infections | D030361 | — | — | 1 | 7 | 19 | 6 | 8 | 41 |
| Uterine cervical neoplasms | D002583 | — | — | 2 | 3 | 9 | 3 | 5 | 22 |
| Papilloma | D010212 | — | — | 2 | 1 | 5 | 2 | 5 | 15 |
| Infections | D007239 | EFO_0000544 | — | — | 2 | 2 | 2 | 3 | 9 |
| Alphapapillomavirus | D052685 | — | — | 1 | 1 | 1 | 1 | 3 | 7 |
| Uterine cervical dysplasia | D002578 | EFO_1000910 | N87 | 1 | 1 | 2 | 3 | — | 7 |
| Neoplasms | D009369 | — | C80 | — | 2 | 1 | 2 | — | 5 |
| Communicable diseases | D003141 | — | — | — | 1 | 2 | 1 | — | 4 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 1 | 1 | 2 | 4 |
| Adenocarcinoma in situ | D065311 | — | — | — | — | 2 | 1 | — | 3 |
Show 14 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Condylomata acuminata | D003218 | EFO_0007147 | A63.0 | 1 | 2 | 14 | — | 2 | 19 |
| Vaginal neoplasms | D014625 | — | C52 | 1 | 2 | 4 | — | 1 | 8 |
| Vulvar neoplasms | D014846 | — | C51 | 1 | 2 | 4 | — | 1 | 8 |
| Papillomaviridae | D027383 | — | — | 2 | 1 | 1 | — | 2 | 6 |
| Anus neoplasms | D001005 | EFO_0003835 | C21 | — | 2 | 1 | — | 1 | 4 |
| Healthy volunteers/patients | — | — | — | 2 | — | 1 | — | — | 3 |
| Virus diseases | D014777 | — | B34 | — | — | 1 | — | 1 | 2 |
| Recurrence | D012008 | — | — | — | 1 | 1 | — | — | 2 |
| Squamous intraepithelial lesions of the cervix | D065310 | — | — | — | 1 | 1 | — | — | 2 |
| Whooping cough | D014917 | EFO_0000650 | A37 | — | — | 2 | — | — | 2 |
Show 11 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Female genital diseases | D005831 | EFO_0009549 | N85 | — | 1 | — | — | — | 1 |
| Genital diseases | D000091662 | — | — | — | 1 | — | — | — | 1 |
| Squamous cell carcinoma | D002294 | — | — | — | 1 | — | — | — | 1 |
| Squamous intraepithelial lesions | D000081483 | — | — | — | 1 | — | — | — | 1 |
| Precancerous conditions | D011230 | — | — | — | 1 | — | — | — | 1 |
| Penile neoplasms | D010412 | — | C60 | — | 1 | — | — | — | 1 |
| Disease | D004194 | EFO_0000408 | R69 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | 1 | — | — | — | 1 | 2 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vaccinia | D014615 | — | — | — | — | — | — | 1 | 1 |
| Hiv seropositivity | D006679 | — | — | — | — | — | — | 1 | 1 |
| Emergencies | D004630 | — | — | — | — | — | — | 1 | 1 |
| Postpartum period | D049590 | — | — | — | — | — | — | 1 | 1 |
| Juvenile arthritis | D001171 | EFO_1002007 | M08 | — | — | — | — | 1 | 1 |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Gardasil – Merck & Co
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
191 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use